Therapeutic Treatment for Benign Prostatic Hyperplasia
6 Angebote vergleichen
Bester Preis: € 108,49 (vom 15.10.2016)1
Symbolbild
Therapeutic Treatment for Benign Prostatic Hyperplasia (2005)
EN HC NWISBN: 9781841846019 bzw. 1841846015, in Englisch, CRC Press, gebundenes Buch, neu.
Von Händler/Antiquariat, PBSonDemand [60689054], Gloucestershire, United Kingdom.
This book is printed on demand. As soon as we receive your order we will start creating your book. Please allow 5 days for it to be printed, packaged and posted.
This book is printed on demand. As soon as we receive your order we will start creating your book. Please allow 5 days for it to be printed, packaged and posted.
2
Kirby, Roger S / McConnell, John D. / Fitzpatrick, John / Roehrborn, Claus G. / Wyllie, Michael / br/Boyle, Peter (eds.)
Therapeutic Treatment for Benign Prostatic Hyperplasia
EN HC NWISBN: 9781841846019 bzw. 1841846015, in Englisch, Informa Healthcare, gebundenes Buch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
buecher.de GmbH & Co. KG, [1].
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.202 pages - Crown quarto (246x189mm)Versandfertig in über 4 Wochen, Hardcover.
buecher.de GmbH & Co. KG, [1].
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.202 pages - Crown quarto (246x189mm)Versandfertig in über 4 Wochen, Hardcover.
3
Editor: Roger S. Kirby, Editor: John D. McConnell, Editor: John Fitzpatrick, Editor: Claus G. Roehrborn, Editor: Michael Wyllie, Editor: Peter Boyle
Therapeutic Treatment for Benign Prostatic Hyperplasia (2005)
EN HC US FEISBN: 9781841846019 bzw. 1841846015, in Englisch, 210 Seiten, CRC Press, gebundenes Buch, gebraucht, Erstausgabe.
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days.
Von Händler/Antiquariat, dandylionbooks.
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease., Hardcover, Ausgabe: 1, Label: CRC Press, CRC Press, Produktgruppe: Book, Publiziert: 2005-07-12, Studio: CRC Press, Verkaufsrang: 13022568.
Von Händler/Antiquariat, dandylionbooks.
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease., Hardcover, Ausgabe: 1, Label: CRC Press, CRC Press, Produktgruppe: Book, Publiziert: 2005-07-12, Studio: CRC Press, Verkaufsrang: 13022568.
4
Editor: Roger S. Kirby, Editor: John D. McConnell, Editor: John Fitzpatrick, Editor: Claus G. Roehrborn, Editor: Michael Wyllie, Editor: Peter Boyle
Therapeutic Treatment for Benign Prostatic Hyperplasia (2005)
EN HC US FEISBN: 9781841846019 bzw. 1841846015, in Englisch, 210 Seiten, CRC Press, gebundenes Buch, gebraucht, Erstausgabe.
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days.
Von Händler/Antiquariat, Full Paper Jacket.
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease., Hardcover, Ausgabe: 1, Label: CRC Press, CRC Press, Produktgruppe: Book, Publiziert: 2005-07-12, Studio: CRC Press, Verkaufsrang: 14369165.
Von Händler/Antiquariat, Full Paper Jacket.
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease., Hardcover, Ausgabe: 1, Label: CRC Press, CRC Press, Produktgruppe: Book, Publiziert: 2005-07-12, Studio: CRC Press, Verkaufsrang: 14369165.
5
Editor: Roger S. Kirby, Editor: John D. McConnell, Editor: John Fitzpatrick, Editor: Claus G. Roehrborn, Editor: Michael Wyllie, Editor: Peter Boyle
Therapeutic Treatment for Benign Prostatic Hyperplasia (2005)
EN HC NW FEISBN: 9781841846019 bzw. 1841846015, in Englisch, 210 Seiten, CRC Press, gebundenes Buch, neu, Erstausgabe.
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days.
Von Händler/Antiquariat, sweethomeliquid2.
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease., Hardcover, Ausgabe: 1, Label: CRC Press, CRC Press, Produktgruppe: Book, Publiziert: 2005-07-12, Studio: CRC Press, Verkaufsrang: 14369165.
Von Händler/Antiquariat, sweethomeliquid2.
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease., Hardcover, Ausgabe: 1, Label: CRC Press, CRC Press, Produktgruppe: Book, Publiziert: 2005-07-12, Studio: CRC Press, Verkaufsrang: 14369165.
Lade…